In a patient with renovascular hypertension who presents with jaw ache, what is the appropriate evaluation and management, including ruling out myocardial ischemia and addressing the hypertension?

Jaw Ache in Renovascular Hypertension: Urgent Cardiac Evaluation Required

In a patient with renovascular hypertension presenting with jaw ache, immediately evaluate for myocardial ischemia with ECG and troponin, as jaw pain is a recognized manifestation of cardiac ischemia through convergence of visceral and somatic pain pathways at the trigeminal nucleus 1.

Immediate Cardiac Assessment

The jaw ache in this clinical scenario is concerning for anginal equivalent and demands urgent cardiac workup:

• Obtain 12-lead ECG immediately - look for ST-segment changes, T-wave inversions, or new Q waves
• Measure cardiac troponins (high-sensitivity if available)
• Consider stress testing or coronary angiography if initial workup is equivocal but clinical suspicion remains high

The neuroanatomical basis for jaw pain during myocardial ischemia involves convergence of cardiac visceral afferents with somatic trigeminal pathways in the brainstem, making jaw pain a legitimate cardiac symptom that should never be dismissed 1.

Critical Context: Renovascular Hypertension and Cardiac Risk

Patients with renovascular hypertension face substantially elevated cardiovascular risk. Research demonstrates that renovascular hypertensive patients show "inappropriately" low coronary blood flow relative to perfusion pressure, creating a critical region where the heart cannot adequately adapt coronary flow to metabolic demands 2. This pathophysiology explains the higher propensity for myocardial ischemia in this population, even without obstructive coronary disease.

Common pitfall: Assuming jaw pain is dental or TMJ-related in a hypertensive patient without first ruling out cardiac ischemia can be fatal.

Hypertension Management Strategy

Once cardiac ischemia is addressed, focus on aggressive medical management of the renovascular hypertension:

Medical therapy is the primary treatment approach for atherosclerotic renovascular disease, as multiple randomized trials (including CORAL) have failed to demonstrate benefit of revascularization over optimal medical therapy for most patients 3.

Optimal Medical Regimen:

• ACE inhibitors or ARBs are appropriate despite theoretical concerns about bilateral disease (monitor creatinine closely)
• Thiazide-type diuretics (chlorthalidone preferred for resistant hypertension)
• Calcium channel blockers
• Beta-blockers if concurrent coronary disease confirmed
• Target blood pressure control aggressively

3

When to Consider Revascularization

Revascularization may be warranted only in specific high-risk scenarios not adequately represented in randomized trials 3:

• Progressive, rapid decline in kidney function despite medical therapy
• Recurrent "flash" pulmonary edema
• Truly refractory hypertension (failure of ≥3 medications including a diuretic at optimal doses)
• Absence of severe albuminuria (better outcomes post-intervention) 3

Important distinction: Fibromuscular dysplasia (typically younger women) may achieve cure with angioplasty, whereas atherosclerotic disease rarely benefits from revascularization 3.

Diagnostic Imaging for Renovascular Disease

If renovascular hypertension diagnosis needs confirmation, the ACR Appropriateness Criteria recommend 4:

• First-line: Renal duplex ultrasound with Doppler (rating 9/9, no radiation)
• Second-line: MRA abdomen without contrast (rating 7/9) if ultrasound inadequate
• CTA has lower appropriateness rating (5/9) due to radiation and contrast nephropathy risk

Avoid routine screening angiography - reserve for when revascularization is being seriously considered based on clinical criteria.

Clinical Algorithm Summary

1. Jaw pain → Immediate cardiac evaluation (ECG, troponin, ± stress test/angiography)
2. If cardiac ischemia confirmed → Treat per ACS protocols; consider combined cardiac and renal revascularization only if both meet criteria 5
3. Optimize medical therapy for renovascular hypertension regardless of revascularization decision
4. Consider revascularization only for progressive renal dysfunction, flash pulmonary edema, or truly refractory hypertension
5. Monitor closely - renovascular disease indicates systemic atherosclerosis with high cardiovascular mortality risk 3

Critical caveat: The combination of renovascular hypertension and cardiac symptoms represents high-risk systemic vascular disease requiring aggressive risk factor modification beyond blood pressure control alone (lipid management, antiplatelet therapy, smoking cessation).